Child Examinations | North Tonawanda, NY

After Hour Nurse Advice Lines
phone iconPhone: (716) 807-7337
phone iconFax: (716) 213-4400
Receive our Health e-Newsletter


News for Healthier Living

New Regimen Protects Against Cancer Relapse, Graft-Versus-Host Disease After Donor Stem Cell Transplant

Results of a phase 1 clinical trial show that patients who undergo a blood stem cell transplant involving a donor have a lower risk of relapse and lower rates of graft-versus-host disease when they receive the targeted therapy VIC-1911 along with the standard-of-care regimen that includes post-transplant cyclophosphamide and sirolimus.

March 20, 2026


April 1 2026

March 31 2026

March 30 2026

March 29 2026

March 28 2026

March 27 2026

March 26 2026

March 25 2026

March 24 2026

March 23 2026

March 22 2026

March 21 2026

March 20 2026

March 19 2026

March 18 2026